Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (211-220 of 362) with videos related to

Pageof 37
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 19, 2022
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trialSolange Peters, Igor Letovanec, Murielle Mauer, et al.
JAMA Oncology|March 10, 2022
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised PatientsMichel Obeid, Madeleine Suffiotti, Celine Pellaton, et al.
Plos One|June 7, 2024
A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trialCarole Bandiera, Evelina Cardoso, Isabella Locatelli, et al.
The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
Oncoimmunology|February 1, 2021
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinomaJan Budczies, Martina Kirchner, Klaus Kluck, et al.
Revue Medicale Suisse|January 28, 2021
[2020 oncology update]Giovanni Dei Tos, Ilianna Galli Vareia, Alexandre Huber, et al.
JAMA Oncology|September 2, 2021
COVID-19 and Cancer: A Review of the Registry-Based Pandemic ResponseAakash Desai, Turab J Mohammed, Narjust Duma, et al.
The New England Journal of Medicine|June 7, 2017
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung CancerSolange Peters, D Ross Camidge, Alice T Shaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 17, 2016
Apnea-like suppression of respiratory motion: First evaluation in radiotherapyNicolas Péguret, Mahmut Ozsahin, Michele Zeverino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 28, 2026
Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapyEtienne Abdelnour-Berchtold, Louis-Emmanuel Chriqui, Laetitia Zermatten, et al.
Pageof 37

Showing results (211-220 of 362) with videos related to

Sort By:
Pageof 37
Lung Cancer (Amsterdam, Netherlands)|December 19, 2022
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trialSolange Peters, Igor Letovanec, Murielle Mauer, et al.
JAMA Oncology|March 10, 2022
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised PatientsMichel Obeid, Madeleine Suffiotti, Celine Pellaton, et al.
Plos One|June 7, 2024
A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trialCarole Bandiera, Evelina Cardoso, Isabella Locatelli, et al.
The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
Oncoimmunology|February 1, 2021
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinomaJan Budczies, Martina Kirchner, Klaus Kluck, et al.
Revue Medicale Suisse|January 28, 2021
[2020 oncology update]Giovanni Dei Tos, Ilianna Galli Vareia, Alexandre Huber, et al.
JAMA Oncology|September 2, 2021
COVID-19 and Cancer: A Review of the Registry-Based Pandemic ResponseAakash Desai, Turab J Mohammed, Narjust Duma, et al.
The New England Journal of Medicine|June 7, 2017
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung CancerSolange Peters, D Ross Camidge, Alice T Shaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 17, 2016
Apnea-like suppression of respiratory motion: First evaluation in radiotherapyNicolas Péguret, Mahmut Ozsahin, Michele Zeverino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 28, 2026
Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapyEtienne Abdelnour-Berchtold, Louis-Emmanuel Chriqui, Laetitia Zermatten, et al.
Pageof 37